NEW RESEARCH CAN BE A POTENTIAL LEAD FOR EARLIER DIAGNOSIS TO CHILDREN WITH AUTISM
A new research points that metabolic signatures in the blood of some children with autism spectrum disorder (ASD) can possibly lead to earlier diagnosis and perhaps targeted therapy.
In the study published in Biological Psychiatry, investigators found that dysregulation of amino acid metabolism can be used in detecting about 17 % of children with ASD.
With no currently strong diagnostic biomarkers for ASD, researchers were forced to turn to prior evidence indicating that dysregulation of branched-chain amino acids may be responsible in contributing ASD, testing whether dysregulation of amino acids is a pervasive phenomenon in individuals with ASD.
“Our paper indicates that that seems to be the case,” said senior author David G. Amaral, PhD, director of research at the University of California, Davis, MIND Institute in Sacramento.
The researchers compared plasma metabolites from over 500 children with ASD with those of 164 age-appropriate children with typical patterns of development. The results allowed the researchers to divide the children with ASD into appropriate subpopulation based upon shared metabolic signatures.
While Dr. Amaral recognizes the unlikelihood of a single biomarker to detect all cases of autism, he says a realistic goal is the formation of a collection of diagnostic panels identifying a large sample of children at risk.
Erudite Nursing Institute™ encourages the development of this study to further improve understanding about autism condition among children creating new feats for earlier detection and possible therapy.
Note: The foregoing article is copyrighted and may not be reproduced in part or entirety without advance written permission. For permissions or editorial corrections, contact: Ms. Kelsey Hanna, khanna@EruditeNursing.education